Core Viewpoint - YY Group Holding Limited has announced an amendment to its previously announced registered direct offering, which includes the sale of Class A Ordinary shares and warrants [1][2]. Offering Details - The company will offer 9,523,812 Class A Ordinary shares and warrants to purchase up to 14,285,718 Class A Ordinary Shares at a purchase price of $0.42 per share [2]. - The warrants have an exercise price of $0.50 per share and a term of 3.5 years [2]. - Gross proceeds from the offering are expected to be approximately $4.0 million, assuming no exercise of the warrants [3]. Use of Proceeds - The net proceeds from this offering are expected to be used for working capital and general corporate purposes [3]. Closing and Regulatory Information - The offering is expected to close on or about September 11, 2025, subject to customary closing conditions [4]. - The offering is being made pursuant to the company's shelf registration statement filed with the U.S. Securities and Exchange Commission [4]. Company Overview - YY Group Holding Limited is a technology-enabled platform providing flexible workforce solutions and integrated facility management services across Asia and beyond [7]. - The company operates through two core verticals: on-demand staffing and integrated facility management, serving industries such as hospitality, logistics, retail, and healthcare [7]. Operational Strategy - The company leverages proprietary digital platforms and IoT-driven systems to help clients meet fluctuating labor demands and maintain high-performance environments [8]. - YY Group has a growing presence not only in Singapore and Malaysia but also across Asia, Europe, the Middle East, and other international markets including the UK, Germany, and Australia [8].

Core Viewpoint - EpicQuest Education Group International Limited has entered into a securities purchase agreement for the sale of 5,068,493 ordinary shares at a price of $0.73 per share, aiming to raise approximately $3.7 million for working capital and general corporate purposes [1][2]. Group 1: Offering Details - The offering is being facilitated by FT Global Capital, Inc. as the exclusive placement agent, with the closing expected around August 26, 2025, pending customary closing conditions [2]. - The gross proceeds from the offering are anticipated to be approximately $3.7 million before deducting fees and expenses [2]. Group 2: Company Overview - EpicQuest Education provides higher education solutions for domestic and international students in the US, Canada, and the UK, operating EduGlobal University in British Columbia and holding a 70% stake in Davis University in Toledo, Ohio [4]. - The company has established a subsidiary, Gilmore Inv LLC, in Ohio to offer international educational programs related to kinesiology and recreation education, and formed SouthGilmore LLC for sports-related entertainment projects [4].

Core Viewpoint - Scienture Holdings, Inc. has announced a registered direct offering to institutional investors, aiming to raise approximately $3.9 million by selling 3,225,000 shares of common stock at $1.20 per share, with the offering expected to close on August 15, 2025 [1]. Group 1: Offering Details - The offering involves 3,225,000 shares at an offering price of $1.20 per share, with gross proceeds expected to be around $3.9 million before fees and expenses [1]. - Maxim Group LLC is acting as the sole placement agent for this offering [2]. - The offering is made under an effective shelf registration statement on Form S-3, filed with the SEC on August 1, 2025, and declared effective on August 8, 2025 [3]. Group 2: Company Overview - Scienture Holdings, Inc. operates through its subsidiary, Scienture, LLC, focusing on developing and distributing novel specialty pharmaceutical products to meet unmet market needs [5]. - The company is committed to enhancing value for patients, physicians, and caregivers through its unique specialty products [5]. - Scienture's assets in development span various therapeutic areas and market segments [5].

Company Overview - Ocugen, Inc. is a biotechnology leader specializing in gene therapies for blindness diseases, focusing on a modifier gene therapy platform that addresses complex diseases caused by imbalances in multiple gene networks [5] Offering Details - The company closed a registered direct offering with Janus Henderson Investors for 20,000,000 shares of common stock at a price of $1.00 per share, along with warrants to purchase an additional 20,000,000 shares at an exercise price of $1.50 per share [1][3] - The gross proceeds from the offering were approximately $20 million, which is expected to extend the company's cash runway into the second quarter of 2026 [3] - If the warrants are fully exercised, the company could receive up to an additional $30 million, potentially extending the cash runway into the first quarter of 2027 [3] Financial Advisors - Noble Capital Markets, Inc. acted as the sole placement agent for the offering, while Maxim Group LLC and Titan Partners Group served as independent financial advisors [2]

Core Viewpoint - Erayak Power Solution Group Inc. has successfully closed a registered direct offering, raising approximately $7 million through the sale of 107,692,307 Class A ordinary shares at a price of $0.065 per share [1][2]. Group 1: Offering Details - The offering involved the sale of Class A ordinary shares and pre-funded warrants, with a purchase price of $0.065 per share [1]. - The gross proceeds from the offering are estimated to be around $7 million, before deducting fees and expenses [2]. - Craft Capital Management LLC served as the sole placement agent for the offering [2]. Group 2: Regulatory Compliance - The offering was conducted under a "shelf" registration statement on Form F-3, which was filed with the SEC and declared effective on May 16, 2024 [3]. - The terms of the public offering were described in a prospectus supplement filed with the SEC [4]. Group 3: Company Overview - Erayak specializes in manufacturing, research and development, and wholesale and retail of power solution products, including inverters, generators, and smart chargers [6]. - The company's products are primarily used in agricultural and industrial vehicles, recreational vehicles, and outdoor living products [6].

Group 1 - Erayak Power Solution Group Inc. has entered into a securities purchase agreement for the sale of 30,612,246 Class A ordinary shares at a price of $0.098 per share, resulting in expected gross proceeds of approximately $3 million [1][2] - The transaction is anticipated to close on or about July 28, 2025, pending customary closing conditions [2] - The offering is conducted under a shelf registration statement previously filed and declared effective by the U.S. Securities and Exchange Commission on May 16, 2024 [3] Group 2 - The offering will be made only through a prospectus supplement and accompanying prospectus, which will be filed with the SEC prior to closing [4] - Copies of the prospectus supplement and accompanying prospectus can be obtained from Craft Capital Management [5] Group 3 - Erayak specializes in manufacturing, research and development, and wholesale and retail of power solution products, including sine wave and off-grid inverters, generators, and smart chargers [6] - The company's products are primarily used in agricultural and industrial vehicles, recreational vehicles, electrical appliances, and outdoor living products [6]

Core Points - Draganfly Inc. has successfully closed a registered direct offering of 4,672,895 units at a price of US$5.35 per unit, resulting in gross proceeds of approximately US$25.0 million [1][2][3] - Each unit consists of one common share and one common share purchase warrant, with the warrants exercisable at CA$7.3579 per share for five years [2] - The net proceeds from the offering will be used for general corporate purposes, including funding new product capabilities, working capital, and research and development [3] Offering Details - The offering was conducted under an effective shelf registration statement filed with the U.S. SEC and a Canadian short form base shelf prospectus [4] - The securities were offered and sold exclusively in the United States, with no sales to Canadian purchasers [4] - A prospectus supplement detailing the offering terms was filed with relevant securities commissions in Canada and the SEC [5] Company Overview - Draganfly Inc. is a pioneer in drone solutions, AI-driven software, and robotics, with over 25 years of innovation in the industry [7] - The company provides solutions for various sectors, including public safety, agriculture, industrial inspections, security, mapping, and surveying [7]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and improve content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]

Core Viewpoint - Stereotaxis, Inc. has announced a registered direct offering to sell approximately $12.5 million of its common stock at a price of $2.00 per share, aimed at accelerating product commercialization and supporting research and development efforts [1][2]. Group 1: Offering Details - The gross proceeds from the offering are expected to be around $12.5 million, with an initial closing of approximately $8.5 million expected on or about July 18, 2025, and a second closing of $4.0 million scheduled for on or before November 25, 2025 [3]. - Lake Street Capital Markets LLC is acting as the exclusive placement agent for the offering [3]. Group 2: Use of Proceeds - Proceeds from the offering will be utilized to accelerate product commercialization, support research and development, and for other corporate purposes [2]. Group 3: Company Overview - Stereotaxis is a leader in surgical robotics for minimally invasive endovascular intervention, with a mission to develop robotic systems and solutions that enhance patient care and operational efficiency [6]. - The company's technology has been used to treat over 150,000 patients globally, indicating a significant market presence [6].

Group 1 - Netcapital Inc. has entered into agreements for the purchase and sale of 641,712 shares of common stock at a price of $4.675 per share in a registered direct offering [1][3] - The offering is expected to generate approximately $3 million in gross proceeds, with an additional potential of $2.9 million from unregistered short-term warrants if fully exercised [3][4] - The company intends to use the net proceeds for the repayment of certain outstanding promissory notes and for general working capital purposes [3] Group 2 - H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering [2] - The common stock is being offered under a "shelf" registration statement that was declared effective by the SEC on October 26, 2022 [4] - The unregistered short-term warrants are being offered in a private placement under Section 4(a)(2) of the Securities Act and have not been registered under the Securities Act or applicable state securities laws [5] Group 3 - Netcapital Inc. is a fintech company that provides a platform for private companies to raise capital online and offers private equity investment opportunities to investors [7] - The company's consulting group, Netcapital Advisors, provides marketing and strategic advice and takes equity positions in select companies [7] - The company's funding portal and broker-dealer are both registered with the SEC and are members of FINRA [7]